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Abstract: 
Despite an increased understanding of nicotine addiction, there is a 
scarcity of research comparing the neural correlates of non-drug reward 
between smokers and ex-smokers. Long-term changes in reward-related 
brain functioning for non-drug incentives may elucidate patterns of 
functioning that potentially contribute to ongoing smoking behaviour in 
current smokers. Similarly, examining the effects of previous chronic 
nicotine exposure during a period of extended abstinence may reveal 
whether there are neural correlates responsible for non-drug reward 
processing that are different from current smokers. The current study, 
therefore, set out to examine the neural correlates of reward and loss 
anticipation, and their respective outcomes, in smokers, ex-smokers and 
matched controls using a monetary incentive delay task during functional 
MRI. Here we report that in the absence of any significant behavioural 
group differences, both smokers and ex-smokers showed a significantly 
greater activation change in the lateral orbitofrontal/anterior insular cortex 
compared to smokers when anticipating both potential monetary gains and 
losses. We further report that ex-smokers showed a significantly greater 
activation change in the ventral putamen compared to both controls and 
smokers, and in the caudate compared to controls during the anticipation 
of potential monetary losses only. The results suggest that smoking may 
sensitize striato-orbitofrontal circuitry subserving motivational processes 
for loss avoidance and reward gain in nicotine addiction. 
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Reviewer: 2 
 
Comments to the Author 
This is a revision of an article detailing brain response differences between smokers, ex-smokers and 
non-smokers using the monetary incentive delay task. The authors did a great job addressing 
previous concerns and clarifying the analysis methods.  
 
A major limitation of the study is the sample size which could only be addressed by recruiting more 
subjects, despite this limitation the study is the first step towards dissociating theoretical models of 
reward processing in smokers.  
 
The inclusion of the mask in the supplemental materials is helpful, however, the inclusion of the 
whole-brain analysis in the supplemental materials would be helpful (although not necessary).  The 
exploratory whole brain analysis demonstrates that the ROI approach did not miss any key reward 
processing regions. 
 
New Author Response: We have now included the ROI mask as a supplementary figure. 
  
Reviewer: 1 
 
Comments to the Author 
Summary 
 
This report titled ‘Smokers and ex-smokers have shared differences in the neural substrates for 
potential monetary gains and losses’ tests the neural correlates of reward and loss anticipation and 
outcomes via the Monetary Incentive Delay task during fMRI in current cigarette smokers, ex-
smokers, and non-smoking young adults. This reviewer continues to have no major concerns, but 
there were some responses that may require further thought and elaboration (outlined below) 
before this paper is accepted for publication. 
 
Materials and Methods 
 
fMRI Data Analysis 
 
1. Coregistration and normalization: it is possible that, due to imperfection/imprecision of standard 
coregistration and normalization algorithms in standard fMRI statistical packages such as FSL, 
activations could appear in lateral OFC, but may actually originate from anterior insula or other areas 
in close approximation to lateral OFC. This could have consequences on the interpretation of the 
data (see Stoeckel et al., Addiction Biology, 2015) for brief discussion of this point and a suggested 
alternative coregistration and normalization approach, which should result in improved 
coregistration and normalization). This reviewer is not recommending that it is necessary to use this 
approach, but this issue should be addressed in some way – either with additional analyses or in 
text. 
 
Author Response: We have reported the peak voxel coordinates that come from a cluster in the OFC 
following cluster-based unpaired t-test analyses in FSL when searching for group differences across 
the OFC and striatal (caudate, putamen and nucleus accumbens) ROI mask taken from the Harvard- 
Oxford atlas. We acknowledge that these OFC clusters also appear to cover the anterior edges of the 
insula, which likely comes from the Harvard-Oxford OFC masks partially abutting the anterior insular 
cortex. We also now refer to the activations as the OFC and the insula throughout the results and 
discussion sections. We used FLIRT (FMRIB's Linear Image Registration Tool), which is a fully 
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automated tool for linear (affine) intra- and inter-modal brain image registration in FSL. We also 
acknowledge that this method of registration might not be the most optimal for anatomical 
localisation. We are happy to acknowledge this as a potential limitation, and mention the anterior 
insular cortex as a region where the group differences may also be emerging. We have now inserted 
the following text under limitations in the discussion as follows: 
 
“Imperfections of standard coregistration and normalization algorithms in FSL may also mean that 
the group differences reported in the lateral OFC may also have included a contribution from the 
anterior insular cortex, which is implicated in addiction, particular relapse.” 
 
Reviewer Response: It would be helpful if the authors provided more detail about the implications 
for activations originating from lateral OFC vs. anterior insula, as there are quite different functions 
in these different networks. For example, anterior insular networks may have special relevance for 
nicotine addiction (vs. addiction more broadly). The information in the Discussion should be added 
to the Introduction and the paper should be revisited to entertain potential hypotheses for what 
would be expected if activation changes were driven by lateral OFC vs. anterior insula networks (or 
both). The localization issue is not just a limitation, but may have implications for how these data are 
interpreted. More attention and thought should be given to this, especially given this was a concern 
raised by both reviewers. 
 
New Author Response: We have now inserted the following information into the introduction: 
 
“Previous and sustained substance use may also have a sensitizing effect in regions connected to, 
but outside, the striatum, such as the insular and orbitofrontal cortices, that represent 
motivational drive (Goldstein et al., 2007) and emotional and interoceptive states (Critchley et al., 
2004; Terasawa et al., 2013).” 
 
We have also entered the updated the discussion to include the following: 
 
“Activations originating in the anterior insular cortex (versus the lateral OFC) may further suggest 
that there is a disproportionate weighting of interoception in response to cues that signal non-
drug rewards. This weighting may represent a sensitization of the lateral insular cortex by previous 
nicotine exposure, which through its connections with the OFC, represents a heightened 
motivational drive (Goldstein et al., 2007) and emotional and i teroceptive state (Critchley et al., 
2004; Terasawa et al., 2013) during non-drug reward expectancy.”   
  
 
2. Motion parameters: there is no mention of whether groups were compared on motion 
parameters or other outlier volumes in the fMRI data that could differ by groups. Please discuss. 
 
New Author Response: The groups did not differ with respect to motion. We have inserted the 
following text in the results section as follows: 
 
“Finally, we did not observe any differences in motion (mean absolute displacement in millimetres) 
between the groups (F=1.4; df=37, 2; p=0.3; control 0.21 ± 0.03; smoker 0.28 ± 0.05; ex-smoker 
0.29 ± 0.03) when acquiring the MID images.”   
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Results 
 
1. FTND scores are roughly equivalent between current and ex-smokers. This must be a mistake as 
ex-smokers should not have an FTND score mean ~3. Please discuss. 
 
Author Response: The FTND score in ex-smokers is a retrospective score acquired during screening 
that reflects the dependence level of the ex-smokers when they were active smokers. We thought 
that it was important to match smokers and ex-smokers on this measure in order to allay concerns 
regarding the influence of former dependence levels on any potential neural differences that 
emerged between the two groups. We have now reported this rationale in the methods section 
(under questionnaires) as follows: 
 
“We also administered the FTND to ex-smokers, retrospectively, in order to match their previous 
levels of nicotine dependence (when they were active smokers) to current smokers. The rationale 
for this was to eliminate previous dependency levels in ex-smokers as a potential contributing factor 
to neural differences with smokers.” 
 
Reviewer Response: The authors should also acknowledge the limitations of a retrospective 
reporting of FTND in ex-smokers, and should list (if the information is available) the mean and range 
in years since the last cigarette (to provide the reader with some sense for how much 
“remembering” was needed to report retrospective FTND). It is possible that these reports are quite 
inaccurate. 
 
 
New Author Response: Information about average abstinence (time since last cigarette) is in table 
1. We have also calculated the range of nicotine abstinence and entered this information into the 
results section (under demographics) as follows: 
 
“The ex-smoker group had been abstinent from nicotine, on average, nearly 85 weeks (range: 52-
180 weeks) at the time of testing.” 
 
We acknowledge that there may be some limitations to retrospectively recording a FTND score 
(i.e. inaccuracies in remembering in the ex-smoker); although as we state, the rationale was to 
match ex-smokers on their previous levels of nicotine dependence (when they were active 
smokers) to current smokers, and this was the only viable way in which to do so. We have, 
however, now inserted the following text under limitations in the discussion as follows: 
 
“There may also have been a limitation of retrospectively recording previous dependency in our 
ex-smoker sample, given the large range of abstinence, potentially contributing to some 
inaccuracies in remembering.” 
 
2. FTND scores are in the low to moderate dependence range for current smokers, possibly due to 
the mean age of this group (young adults). This should be addressed in the Discussion section, 
especially how this may limit generalizability to more dependent  and/or older smokers. 
 
Author Response: We have discussed this as a limitation in the discussion as follows: 
 
“The levels of dependency, for example, may reflect the young age of the smoker and ex-smoker 
groups, where a modest exposure to nicotine may have a sensitizing effect on brain circuitry 
subserving motivational and reward processes. These relatively modest levels of dependency, 
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therefore, may curtail the generalizability of the current findings to greater levels of nicotine 
dependence that are observed in older adults.” 
 
Reviewer Response: The authors should also add that this may curtail generalizability of the current 
findings to more dependent smokers in addition to “older” smokers (i.e., there is a confound 
between age and nicotine dependence). 
 
New Author Response: We have now modified the previous insertion as follows: 
 
“The levels of dependency, for example, may reflect the young age of the smoker and ex-smoker 
groups, where a modest exposure to nicotine may have a sensitizing effect on brain circuitry 
subserving motivational and reward processes. These relatively modest levels of dependency, 
therefore, may curtail the generalizability of the current findings to greater levels of nicotine 
dependence that are observed in older adults (i.e. the confound between age and nicotine 
dependence).” 
 
 
Discussion 
 
1. There is no direct comparison of drug and non-drug reward and loss anticipation and outcome. 
This may limit how these data can inform the relative importance of drug vs. non-drug reward 
alterations related to nicotine addiction. This is also a relatively low-to-moderately dependent 
sample, which also limits interpretation of these data. This should be discussed. 
 
Author Response: We have now discussed the low-moderate nicotine dependence levels of the 
smoker and ex-smoker samples under limitations in the manuscript (also see above). A previous 
study comparing 13 current cigarette smokers, 10 ex-smokers and 13 controls (Nestor et al., 2011) 
did examine neural responses to drug cues (i.e. cigarette images). That study showed that exsmokers 
had significantly less BOLD activation change compared to smokers (but not controls) in the ventral 
striatum while viewing smoking images. These are the same subjects, apart from two additional 
volunteers recruited into the smoker and control groups. While we cannot make a direct comparison 
of drug and non-drug rewards in this study, we can speculate the same ten ex-smokers appeared to 
have a neural shift in the attribution of incentive salience between “drug” and non-drug reward. The 
inclusion of a drug condition, whereby cigarettes could also have been received as rewards (i.e. drug 
rewards), we believe, would not have been appropriate or ethical in the abstinent 
(ex-smoker) group. Therefore, we have inserted the following text in the discussion to address the 
reviewer’s comment: 
 
“Interestingly, this same sample of ex-smokers demonstrated reduced activation changes in the 
ventral striatum compared to smokers while viewing smoking stimuli (Nestor et al., 2011), 
suggesting a neural shift in the attribution of salience between drug and non-drug predictive cues in 
the striatum during abstinence.” 
 
Reviewer Response: Again, given there is no direct comparison with non-drug reward, it is not clear 
to this reviewer that this conclusion can be made. In addition, this language does not clearly 
differentiate what is added by the current study (vs. the cited Nestor et al., 2011 study) in this area. 
It is this reviewer’s opinion that this should clearly be stated as a limitation (vs. making a speculative 
statement not based in data). If there are data to support this contention, the case needs to be 
made more clearly. 
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New Author Response: We have discussed this as a limitation in the discussion as follows: 
 
“Furthermore, we were not able to make a direct comparison regarding the neural correlates of 
drug (smoking) and non-drug reward anticipation and outcome processing, which may limit how 
our findings can inform the relative importance of reward alterations in nicotine addiction.” 
 
Figures 2 and 3 
 
1. “Lateral OFC” activations appear to be more localized to anterior insula (Figs 2a,b; 3a,d). Anterior 
insula is an important brain region involved addiction, specifically in nicotine addiction (see Stoeckel 
et al., 2015 referenced earlier for further discussion and citations of other seminal work in this area). 
Figs should be modified with this in mind. 
 
Reviewer Response: The authors' response is adequate. 
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Smokers and ex-smokers have shared differences in the neural substrates for 
potential monetary gains and losses 
 
 
Liam J Nestor1, 2, Ella McCabe2, Jennifer Jones2, Luke Clancy3, Hugh Garavan2, 4 
 
 
1Centre for Neuropsychopharmacology, Imperial College London, UK 
 
2School of Psychology and Institute of Neuroscience, Trinity College Dublin, Dublin, 
Ireland 
 
3 TobaccoFree Research Institute Ireland, DIT, Dublin 
 
4Department of Psychiatry, University of Vermont, Burlington, Vermont, USA 
 
Abstract 
Despite an increased understanding of nicotine addiction, there is a scarcity of 
research comparing the neural correlates of non-drug reward between smokers and 
ex-smokers. Long-term changes in reward-related brain functioning for non-drug 
incentives may elucidate patterns of functioning that potentially contribute to ongoing 
smoking behaviour in current smokers. Similarly, examining the effects of previous 
chronic nicotine exposure during a period of extended abstinence may reveal 
whether there are neural correlates responsible for non-drug reward processing that 
are different from current smokers. The current study, therefore, set out to examine 
the neural correlates of reward and loss anticipation, and their respective outcomes, 
in smokers, ex-smokers and matched controls using a monetary incentive delay task 
during functional MRI. Here we report that in the absence of any significant 
behavioural group differences, both smokers and ex-smokers showed a significantly 
greater activation change in the lateral orbitofrontal/anterior insular cortex compared 
to smokers when anticipating both potential monetary gains and losses. We further 
report that ex-smokers showed a significantly greater activation change in the 
ventral putamen compared to both controls and smokers, and in the caudate 
compared to controls during the anticipation of potential monetary losses only. The 
results suggest that smoking may sensitize striato-orbitofrontal circuitry subserving 
motivational processes for loss avoidance and reward gain in nicotine addiction.          
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Introduction 
 
Nicotine and other drugs of addiction are conceived to commandeer some of 
the same neural substrates which have evolved to support beneficial forms of 
synaptic plasticity, such as learning and memory (Gerdeman et al., 2003).  
Laboratory studies in animals and humans have demonstrated nicotine-induced 
dopamine (DA) release within striatal regions of the brain (Domino et al., 2012), 
which is believed to underlie nicotine’s reinforcing properties (Tuesta et al., 2011). 
Striatal regions are also critical neuroanatomical substrates for the processing of 
non-drug rewards in humans (Knutson et al., 2001; O'Doherty et al., 2006) and 
underlie incentive salience systems for goal-objects (Knutson et al., 2005; McClure 
et al., 2004). Therefore, drugs such as nicotine, capable of engaging striatal “reward 
circuitry”, may potentially alter neural processing for non-drug rewards. 
 
Disturbances in reward-related brain functioning for non-drug incentives may 
elucidate adaptations in neural circuitry that contribute to ongoing smoking 
behaviour in humans. The reward deficiency syndrome (RDS) (Blum et al., 2000) 
and the allostatic hypotheses (AH) (Koob et al., 2004), for example, view addiction 
as a deficit in DA motivational circuitry for non-drug incentives, such that only 
substances of abuse are able to normalize DA in fronto-striatal regions. The current, 
but limited, literature does suggest that chronic smokers have deficits in striatal DA 
integrity similar to other addiction populations (Fehr et al., 2008) and reduced 
reward-related neural activity for non-drug incentives (Rose et al., 2012), appearing 
to concur with an RDS view of nicotine addiction. Substance-dependent groups, 
however, have also been shown to exhibit both impulsive and reward-centred choice 
behaviours, particularly involving an increased preference for small immediate over 
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larger delayed non-drug rewards (Bechara et al., 2001), suggesting some type of 
mesolimbic reward hyperactivity (Bickel et al., 2007). Indeed, smokers (Martin et al., 
2014), cannabis users (Filbey et al., 2013; Nestor et al., 2010), alcoholics (Gilman et 
al., 2015; Grodin et al., 2016) and even cocaine addicts in sustained abstinence 
(Balodis et al., 2016) have been reported to demonstrate hyperactivity in striatal 
regions during the pursuit of non-drug incentives. Previous and sustained substance 
use may also have a sensitizing effect in regions connected to, but outside, the 
striatum, such as the insular and orbitofrontal cortices, that represent motivational 
drive (Goldstein et al., 2007) and emotional and interoceptive states (Critchley et al., 
2004; Terasawa et al., 2013). This would appear to oppose the notion of an RDS in 
some addiction populations, instead suggesting heightened and indiscriminate 
neural responses to cues that signal all forms of potential reward.  
 
While the majority of cigarette smokers endorse the desire to quit, reported 
abstinence rates after twelve months are in the modest region of 5-17% (Hughes et 
al., 2008), with the vast majority relapsing to smoking within a week of 
cessation (Zhu et al., 2012). Executive functioning has been proposed to play a 
significant role in preventing relapse (Buhringer et al., 2008; Garavan et al., 2013), 
and indeed, research has reported that long-term abstinent ex-smokers demonstrate 
hyperactivity in lateral and medial prefrontal regions that sub-serve inhibitory control 
functioning (Kroenke et al., 2015; Nestor et al., 2011). This appears to suggest that 
the emergence of prefrontal cognitive neural substrates are necessary for 
successful abstinence in addiction; although this does not preclude the existence of 
other mechanisms that may explicate changes in neural and behavioural functioning 
that protect against relapse. 
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Therefore, in order to examine the effects of both current and previous 
nicotine exposure on the behavioural and fronto-striatal correlates of non-drug 
incentives, we compared current smokers, ex-smokers and demographically 
matched healthy controls using a monetary incentive delay task. Specifically, we 
were interested in exploring 1) whether smokers and ex-smokers demonstrate 
shared or dissociated differences from controls in the neural response to the 
anticipation, and receipt, of monetary gains and losses in fronto-striatal networks 
and 2) whether such differences imply signs of either an RDS or reward-centred 
correlate in these regions during the pursuit of non-drug incentives.   
 
Material and Methods 
Participants 
15 current cigarette smokers, 10 ex-smokers and 15 controls completed the 
study. A semi-structured interview, as used in previous behavioural and functional 
imaging studies (Carey et al., 2015; Nestor et al., 2010) was conducted to screen 
participants for past or present histories of psychiatric or neurological illness. 
Information pertaining to any form of treatment (counselling, psychological, 
psychiatric), past or present, was carefully detailed, with any potential participant 
describing any major life-time psychiatric event or brain injury (e.g., head trauma 
resulting in a loss of consciousness, seizure or stroke) considered ineligible for the 
study. Participants were also considered ineligible if they reported any familial 
psychiatric history (i.e. sibling, parent or grandparent).  
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During the screening interview, all potential participants completed an 
inventory for drug use (questionnaire taken from the Addiction Severity index Lite-
CF; see questionnaires section below) to screen for past or concurrent abuse of 
substances; participants were considered ineligible if they reported concurrent or 
past dependence on other drugs (e.g., alcohol, amphetamines, barbiturates, 
benzodiazepines, cocaine, hallucinogens, MDMA and opiates). Information 
concerning alcohol and tobacco use in each participant was indexed in years (life-
time) and recent (last 30 days). Other drug use information for each participant was 
indexed by the total number of separate occasions (life-time) and the total number of 
recent separate occasions (last 30 days).  
 
Current smokers were required to have regularly consumed tobacco (≥10 
cigarettes/day) for the previous 2 years in order to be eligible. Ex-smokers were 
required to have regularly consumed tobacco (≥10 cigarettes/day) for at least two 
years, but be nicotine abstinent for at least 12 months at the time of testing. Ex-
smokers were considered eligible if they additionally reported no past or current use 
of products to facilitate nicotine abstinence (e.g., gum, patches, lozenges, nasal 
spray and inhalators). Control participants were required to have never smoked 
cigarettes. Smoking abstinence in ex-smokers and controls was confirmed by 
measuring expired carbon monoxide (CO) in parts per million (ppm) during the 
screening process. All participants in each of the three groups were required to 
provide a negative urine sample for various drugs of abuse on the day of testing, 
specifically screening for the presence of amphetamines, barbiturates, 
benzodiazepines, cannabinoids, cocaine, MDMA, methadone, opiates and tricyclic 
antidepressants (Cozart RapiScan, UK). 
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Because previous research has shown that acute abstinence from cigarettes 
impairs concentration (Heishman, 1999; Newhouse et al., 2004) and increases 
BOLD activation changes during functional MRI (Azizian et al., 2010), cigarette 
smokers each smoked ad lib approximately 15 minutes prior to scanning in order to 
avoid the potential confounds of withdrawal and/or craving on MID task 
performance. Consequently, any differences in current smokers regarding task 
performance or BOLD activation changes could be attributable to the acute effects 
of their recent nicotine use. Given their frequent daily use, this is deemed desirable 
as it reveals the typical functioning of their neural systems. 
 
All participants were right-handed as confirmed by the Edinburgh 
Handedness Inventory (Oldfield, 1971) during the screening process. All participants 
completing the study were neurologically normal (as confirmed by a registered 
radiologist who examined each structural MRI). All research participants provided 
informed consent and were financially compensated. 
 
Questionnaires 
The National Adult Reading Test (NART) (Nelson et al., 1978) was 
administered to all participants during the screening procedure to assess verbal 
intelligence, as was the Beck Depression Inventory (BDI) to assess mood (Beck et 
al., 1996). Information concerning alcohol and drug use (see Table 1) was obtained 
from all participants using a questionnaire taken from the Addiction Severity Index 
Lite-CF (McLellan et al., 1992). During the screening procedure, the Fagerström test 
of nicotine dependence (FTND) was administered to smokers. The FTND 
(Heatherton et al., 1991) is a 6-item questionnaire that measures the degree of 
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nicotine dependence in an individual smoker. We also administered the FTND to ex-
smokers, retrospectively, in order to match their previous levels of nicotine 
dependence (when they were active smokers) to current smokers. The rationale for 
this was to eliminate previous dependency levels in ex-smokers as a potential 
contributing factor to neural differences with smokers.     
 
The Shiffman-Jarvik smoking withdrawal questionnaire (SJWQ) and the urge 
to smoke (UTS) scale were administered to smokers prior to scanning. The 25-item 
SJWQ (Shiffman et al., 1976) asks individuals to respond to questions using a 7-
point Likert-type scale that ranges from “very definitely” (7) to “very definitely not” (1) 
with respect to how they feel at that moment regarding separate withdrawal 
symptoms. These withdrawal symptoms are comprised of craving, physical, 
psychological, sedation and appetite constructs. Each construct is given a mean 
score, with the mean for each construct summed to provide an overall withdrawal 
score for an individual. The 10-item UTS scale (Jarvik et al., 2000) assesses 
responses to craving-related questions, using a 7-point Likert-type scale ranging 
from “very definitely” (7) to “very definitely not” (1). 
 
Monetary Incentive Delay Task (MID) 
We used a “monetary incentive delay task” (MID), which was based on that 
originally employed by Knutson (Knutson et al., 2001) and which we have previously 
used to assess the neural correlates of reward processing in cannabis users (Nestor 
et al., 2010). While being scanned participants performed the MID task, during 
which they anticipated potential monetary gain, loss or no potential monetary 
outcome. During each trial, participants viewed one of three coloured squares (cue) 
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that indicated the potential to gain fifty cent (green square), lose fifty cent (red 
square) or experience no financial outcome (blue square - here referred to as the 
neutral condition) following their response to an upcoming visual target. Each cue 
was presented for a variable duration (2-8 sec), after which participants made a 
button press response upon the presentation of a visual target (star located within a 
circle). Participants received feedback (1500 ms) following their response to the 
visual target, after which there was an end fixation period (2-8 sec) before the 
commencement of the next trial. Responses to the visual target falling within (“hits”) 
or outside (“misses”) a 400ms response deadline received feedback appropriate for 
that particular trial. We chose this 400 ms time frame in order to yield accuracy 
levels at ~50%, which would serve to maintain the participant’s interest in the task. 
Therefore, participants had four hundred milliseconds to respond to the visual target 
in order to be successful on a gain, loss or neutral trial. There were a total of 27 
trials in each condition (gain, loss, and neutral), with each trial lasting between six 
and eighteen seconds. The MID was composed of three runs, with each run lasting 
340 seconds. The order of trials within each run was randomised. Dependent 
measures derived from the data included mean perce tage accuracy and reaction 
time for the gain, loss and neutral conditions. The task was programmed and run 
using E-Prime version 1.1 (Psychology Software Tools, Pittsburgh, USA).    
 
     
Functional MRI (fMRI) Data Acquisition  
All scanning was conducted on a Philips Intera Achieva 3.0 Tesla MR system 
(Best, The Netherlands) equipped with a mirror that reflected the visual display, 
which was projected onto a panel placed behind the participants' head outside the 
magnet. The mirror was mounted on the head coil in each participant’s line of vision. 
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Each scanning sequence began with a reference scan to resolve sensitivity 
variations. A parallel sensitivity encoding (SENSE) approach with a reduction factor 
of 2 was utilised for all T1-weighted image acquisitions (Pruessmann et al., 1999). 
180 high-resolution T1- weighted anatomic MPRAGE axial images (FOV 230 mm, 
thickness 0.9 mm, voxel size 0.9×0.9×0.9) were then acquired (total duration 325 s), 
to allow subsequent activation localization and spatial normalization. Functional data 
were acquired using a T2* weighted echo-planar imaging sequence collecting 32 
non-contiguous (10% gap) 3.5 mm axial slices covering the entire brain (TE=35 ms, 
TR=2000 ms, FOV 224 mm, 64×64 mm matrix size in Fourier space). Functional 
scans had a total duration of 340 s per run. 
 
fMRI Data analyses 
Data pre-processing and statistical analysis were conducted using FEAT 
(fMRI Expert Analysis Tool) from the FMRIB Software Library (FSL 4.1, 
www.fmrib.ox.ac.uk/fsl). Pre-statistical processing was as follows: motion correction 
utilizing FMRIB’s Linear Image Registration Tool (MCFLIRT); non-brain matter 
removal using Brain Extraction Tool (BET); spatial smoothing with a 6-mm full-width 
half maximum Gaussian kernel; mean-based intensity normalization; nonlinear high-
pass temporal filtering (Gaussian-weighted least squares straight line fit, with sigma 
= 25.0 sec).  
 
For each participant, first level whole-brain mixed-effects analyses were 
performed by modelling the MID anticipation periods (i.e., gain, loss and neutral) as 
explanatory variables within the context of the general linear model on a voxel-by-
voxel basis (variable boxcar functions for the anticipation period regressors were 
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convolved with the haemodynamic response function). The gain, loss and neutral 
outcome periods (“Hit” and “Miss”) were also modelled (stick functions for the 
feedback period regressors were convolved with the haemodynamic response 
function). The end fixation period of the task served as the implicit baseline. 
Registration was conducted through a two-step procedure, whereby EPI images 
were first registered to the high-resolution T1 structural image, then into standard 
(Montreal Neurological Institute, MNI avg152 template) space, with 12-parameter 
affine transformations.  
 
As striatal and orbitofrontal regions are critical neural substrates for the 
processing of non-drug rewards in humans (Knutson et al., 2001; O'Doherty et al., 
2001), with evidence for both hypoactivity and hyperactivity to non-drug rewards in 
these regions in addiction populations, we took an a priori region of interest (ROI) 
approach, restricting our search for group differences in these regions. These 
regions were taken from the Harvard-Oxford cortical and subcortical structural atlas 
and grouped together into one ROI mask (see Supplementary Figure 1). Higher-
level (between-group) analyses were conducted using FLAME (FMRIB's Local 
Analysis of Mixed Effects) on each of the gain, loss and neutral anticipation and 
outcome conditions. The end fixation period of the task served as the implicit 
baseline. Therefore, all reported differences between groups on the gain, loss and 
neutral conditions are for activation changes versus the baseline. Significant clusters 
in this ROI mask of a priori regions were determined by thresholding at Z>2.3 with a 
corrected (FWE) cluster significance threshold of p<0.05. 
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Other Statistics 
 For analyses conducted on the MID behavioural data, we performed three 
(Group: Control vs. Ex-smoker vs. Smoker) by three (Condition: Neutral vs. Loss vs. 
Gain) analyses of variance. For further group analyses performed on the mean 
BOLD signal change, we conducted one-way analyses of variance. These analyses 
were all conducted using the Statistical Package for the Social Sciences (SPSS Inc., 
Chicago). 
 
Results 
Demographics 
Table 1 shows the demographic, smoking and alcohol use histories for the 
control, ex-smoker and smoker groups. The groups did not significantly differ on 
age, years of education, verbal intelligence, gender distribution or alcohol use 
history. The ex-smoker group had been abstinent from nicotine, on average, nearly 
85 weeks (range: 52-180 weeks) at the time of testing. 
 
-Insert Table 1 about here- 
 
MID Performance 
Figure 1a shows the mean MID accuracy (% “hits”) for the three conditions in 
the three groups. A three (Group: Control vs. Ex-smoker vs. Smoker) by three 
(Condition: Neutral vs. Loss vs. Gain) analysis of variance showed that there was a 
significant effect of condition (F=5.6; df=111, 2; p<0.01; neutral<loss, p<0.05; 
neutral<gain, p<0.01), but no group (F=0.5; df=111, 2; p=0.6) or condition x group 
interaction (F=0.09; df=111, 4; p=0.99). Figure 2b shows the mean MID reaction 
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time (milliseconds) for the three conditions in the three groups. There was a 
significant effect of condition (F=2.6; df=111, 2; p<0.05; loss<neutral, p<0.09; 
gain<neutral, p<0.05), no effect of group (F=1.4; df=111, 2; p=0.3) and no condition 
x group interaction (F=0.1; df=111, 4; p=1.0). 
 
-Insert Figure 1 about here- 
 
Functional MRI 
We initially conducted mixed effects cluster-based one-way ANOVA analyses 
on the gain, loss and neutral conditions in the priori regions of interest (ROI) mask, 
but we were unable to find a group effect. Therefore, we combined the smoker and 
ex-smoker groups (“smokers”) in order to increase sample size, and performed 
cluster-based independent t-test analyses (Control vs. “Smokers”) to examine 
activation differences on the anticipation and outcome periods in the ROI mask. For 
the loss anticipation condition (Fig 2a) “smokers” showed significantly greater 
activation change in the right orbitofrontal/anterior insular cortex (OFC/AIC: 552 
voxels; x=44; y=20; z=-6; Z=4.1; p<0.05); right putamen (756 voxels; x=20; y=18; 
z=-8; Z=3.65; p<0.01) and the left caudate (734 voxels; x=-10; y=8; z=4; Z=3.36; 
p<0.01) compared to controls. Similarly, for the gain anticipation condition (Fig 2b) 
“smokers” again showed significantly greater activation change in the right OFC/AIC 
(580 voxels; x=46; y=18; z=-10; Z=3.63; p=0.01); right caudate (646 voxels; x=10; 
y=12; z=-2; Z=3.94; p<0.01) and the left putamen (620 voxels; x=-16; y=8; z=-12; 
Z=3.47; p<0.01) compared to controls. There were no cluster-based analysis group 
differences that emerged for the neutral anticipation condition or on the gain, loss 
and neutral outcomes (hits and misses).  
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-Insert Figure 2 about here- 
 
 In order to assess whether the smoker and ex-smoker groups had 
independently contributed to the loss and gain anticipation group differences, we 
extracted the mean BOLD signal change from each of the t-test clusters and 
conducted one-way (Control vs. Ex-smoker vs. Smoker) analyses of variance. For 
the loss anticipation condition, there was a significant effect of group in the right 
OFC/AIC cluster (F=6.6; df=37, 2; p<0.01; ex-smoker>control, p<0.01; 
smoker>control, p<0.05; Fig 3a); the right putamen cluster (F=7.1; df=37, 2; p<0.01; 
ex-smoker>control, p<0.001; ex-smoker>smoker, p<0.05; Fig 3b) and left caudate 
cluster (F=3.6; df=37, 2; p<0.05; ex-smoker>control, p<0.05; Fig 3c). For the gain 
anticipation condition, there was a significant effect of group in only the right 
OFC/AIC cluster (F=4.4; df=37, 2; p<0.05; ex-smoker>control, p<0.05; 
smoker>control, p<0.05; Fig 3d).  
 
Finally, we did not observe any differences in motion (mean absolute 
displacement in millimetres) between the groups (F=1.4; df=37, 2; p=0.3; control 
0.21 ± 0.03; smoker 0.28 ± 0.05; ex-smoker 0.29 ± 0.03) when acquiring the MID 
images.   
       
-Insert Figure 3 about here- 
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Correlations 
We did not find any significant correlations between smoking demographics 
in smokers and ex-smokers and mean percentage BOLD change values within the 
clusters where we observed group differences.     
 
Discussion 
    The present study examined loss and reward processing in cigarette smokers 
and demographically matched ex-smokers and controls using an MID task. 
Behaviourally, we observed no significant differences between the three groups with 
respect to mean accuracy or reaction time. The absence of performance 
differences, therefore, enable us to discount performance related effects (e.g., 
frustration) from confounding group comparisons with respect to the neural 
correlates of loss and gain anticipation. Furthermore, all three groups appeared to 
be equally incentivized to avoid losses and maximize gains, as revealed by the 
statistically significant differences in accuracy and response latencies compared to 
the neutral condition. 
 
Greater OFC activation during loss and gain anticipation in ex-smokers and smokers 
The current study reports that during the anticipation of potential monetary 
losses and gains, smokers, and to a greater degree ex-smokers, had greater 
activation in the lateral OFC. There is evidence that neural responses in the lateral 
OFC reflect both implicit motivational value (Rothkirch et al., 2012) and incentive 
salience (Walter et al., 2010), suggesting that these processes are heightened 
during both loss and gain anticipation in smokers and ex-smokers. These lateral 
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OFC clusters also partially covered a region of the anterior insular cortex. 
Importantly, the insular cortex is known to be involved in the evaluation of 
motivational states, reward, risk (Liu et al., 2011; Preuschoff et al., 2008; Samanez-
Larkin et al., 2007), and addiction relapse (Naqvi et al., 2007; Paulus et al., 2005; 
Seo et al., 2013), with particular reference to its role in the awareness of 
interoceptive (i.e. bodily) states (Critchley et al., 2004). Activations originating in the 
anterior insular cortex (versus the lateral OFC) may further suggest that there is a 
disproportionate weighting of interoception in response to cues that signal non-drug 
rewards. This weighting may represent a sensitization of the lateral insular cortex by 
previous nicotine exposure, which through its connections with the OFC, represents 
a heightened motivational drive (Goldstein et al., 2007) and emotional and 
interoceptive state (Critchley et al., 2004; Terasawa et al., 2013) during non-drug 
reward expectancy. 
  
The incentive-sensitization theory of addiction proposes that sensitized neural 
circuits function to attribute incentive salience to reward-related stimuli, allowing 
reward cues to trigger excessive “wanting” for the reward (Berridge et al., 1998). 
The focus of sensitized “wanting” in addiction, however, is believed to be primarily 
towards drug cues and drug rewards, rather than natural rewards (Robinson et al., 
2001). Despite this contention, sensitization has been shown to enhance the pursuit 
of natural rewards in animals, where exposure to substances of abuse has been 
observed to significantly increase cue-elicited approach behaviour for non-drug 
rewards (Wyvell et al., 2001). Interestingly, a similar effect has also been observed 
in humans, where the neural correlates of reward and loss anticipation are greater in 
cannabis users (Filbey et al., 2013; Nestor et al., 2010), cigarette smokers (Martin et 
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al., 2014), alcoholics (Gilman et al., 2015; Grodin et al., 2016) and even cocaine 
addicts (Balodis et al., 2016). This may suggest that chronic exposure to nicotine 
through smoking sensitizes striato-orbitofrontal circuitry that subserves motivational 
processes for loss avoidance and reward gain. Alternatively, the hyperactivity 
observed in “smokers” may represent a trait-like effect that preceded smoking, but 
that has not “corrected” with abstinence in the ex-smoker group.  
    
Greater striatal activation in ex-smokers during loss anticipation  
We also report that ex-smokers demonstrated a greater activation change in 
the ventral putamen compared to smokers and controls, and compared to controls in 
the caudate during loss anticipation. Previous research has reported altered striatal 
activity for non-drug rewards in substance dependence (Buhler et al., 2010; 
Bustamante et al., 2014; Diekhof et al., 2008; Gradin et al., 2014; Peters et al., 
2011; Wrase et al., 2007) with some evidence for a sustained striatal reward 
deficiency syndrome (Blum et al., 2000) in long-term substance abstinence. The 
current finding of increased ventral putamen and caudate activation in ex-smokers 
suggests that they have an increased motivational signal in a reward-motor network 
where preparatory responses might be optimized to avoid loss. Interestingly, this 
same sample of ex-smokers demonstrated reduced activation changes in the ventral 
striatum compared to smokers while viewing smoking stimuli (Nestor et al., 2011), 
suggesting a neural shift in the attribution of salience between drug and non-drug 
predictive cues in the striatum during abstinence. This should be tempered, 
however, with the fact that differences between ex-smokers and smokers were 
smaller, possibly suggesting some similarities within a network of regions that 
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function to integrate motivational drives (Goldstein et al., 2007) under conditions of 
loss avoidance.  
 
Limitations of the current study involve small sample sizes, particularly in the 
ex-smoker group, and the low-moderate nicotine dependency range in current 
smokers. The levels of dependency, for example, may reflect the young age of the 
smoker and ex-smoker groups, where a modest exposure to nicotine may have a 
sensitizing effect on brain circuitry subserving motivational and reward processes. 
These relatively modest levels of dependency, therefore, may curtail the 
generalizability of the current findings to greater levels of nicotine dependence that 
are observed in older adults (i.e. the confound between age and nicotine 
dependence). There may also have been a limitation of retrospectively recording 
previous dependency in our ex-smoker sample, given the large range of abstinence, 
potentially contributing to some inaccuracies in remembering. Furthermore, we were 
not able to make a direct comparison regarding the neural correlates of drug 
(smoking) and non-drug reward anticipation and outcome processing, which may 
limit how our findings can inform the relative importance of reward alterations in 
nicotine addiction. Imperfections of standard coregistration and normalization 
algorithms in FSL may also mean that the group differences reported in the lateral 
OFC may also have included a contribution from the anterior insular cortex, which is 
implicated in addiction, particular relapse. 
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Conclusion 
 Despite the limitation of a small sample size (in particular, the ex-smoker 
group), and the low-moderate nicotine dependency, the current study has provided 
preliminary evidence for hyperresponsive OFC processing during cue-elicited 
approach behaviour for non-drug rewards in smokers and ex-smokers. This would 
appear to concur with the process of incentive-sensitization, as opposed to the RDS, 
in the current sample. Therefore, we tentatively propose that smokers and ex-
smokers have a neural substrate for predicting potential monetary losses and gains 
that represents a sensitization of striato-orbitofrontal circuitry integrating motivational 
drives and incentive salience for goal objects. 
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Figure 1. MID task performance in the control, ex-smoker and smoker groups for a) mean percentage accuracy (Loss>Neutral - *p<0.05; 
Gain>Neutral - **p<0.01) and b) mean reaction time (Gain<Neutral - **p<0.05). Data were analyzed using 3 (Group: Control vs. Ex-smoker vs. 
Smoker) by 3 (Condition: Neutral vs. Loss vs. Gain) analysis of variance. Data are expressed as means ± SEM. 
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Figure 2. Initial zT-Statistical cluster maps generated by independent t-test analyses (“Smokers” vs. Controls) in the a priori regions of interest 
for a) loss anticipation and b) gain anticipation showing that “smokers” had significantly greater activation changes in orbitofrontal/anterior 
insular cortex and striatal regions compared to controls. Statistical images were first thresholded using clusters determined by Z>2.3 with a 
corrected (FWE) cluster significance level of p<0.05. The scale represents the colour (from dark to light yellow) of the cluster voxels 
corresponding to the increasing zT-statistic. Co-ordinates are represented in Montreal Neurological Institute (MNI) space. 
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Figure 3. Mean BOLD signal change in the control, ex-smoker and smoker showing that a) ex-smokers (**p<0.01) and smokers (*p<0.05) had 
greater activation changes in the orbitofrontal/insular cortex compared to controls; b) ex-smokers had greater activation changes in the 
putamen compared to both controls (*p<0.001) and smokers (*p<0.05); c) ex-smokers (*p<0.05) had greater activation changes in the caudate 
compared to controls during the loss anticipation condition and d) ex-smokers and smokers had greater activation changes in the 
orbitofrontal/anterior insular cortex compared to controls (*p<0.05) during the gain anticipation condition. Data were analyzed using a one-way 
analysis of variance. Data are expressed as means ± SEM. 
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Table 1. Mean and SEM for the control, ex-smoker and smoker groups on demographic, smoking 
and alcohol use history (
†
denotes score prior to abstinence).  
 
 
 
    
     Control 
     (n=15) 
  Ex-smoker 
(n=10) 
Smoker  
(n=15) 
    
    
Age    23.8 + 1.2   25.4 + 1.6 23.3 + 1.2 
Years of Education   18.1 + 0.4   17.9 + 0.9  16.5 + 0.5 
Verbal Intelligence Score (NART) 123.4 + 1.1 123.2 + 1.0  121.5 + 1.0 
Females/Males 7/8  7/3     9/6 
    
Years of Alcohol Use  7.4 + 1.2   9.0 + 1.5    7.6 + 1.1 
Alcohol Use in the Last Month (no. days)   8.1 + 1.6   6.6 + 1.6    8.3 + 1.2 
Alcohol Use Age Onset (Years)   15.5 + 1.2 16.4 + 0.6  15.8 + 0.6 
    
Years of Nicotine Use     7.1 + 1.7    7.1 + 1.3 
Pack-Years 
Number of Cigarettes/Day 
  
  
  5.9 + 1.5 
 16.0 + 2.5
†
 
   6.2 + 1.5 
 16.0 + 1.2 
Nicotine Abstinence (wks)   
  
 84.8  + 13.6 
   
   0.0 + 0.0 
Subscales of Shiffman/Javik Withdrawal Scale 
Craving 
 
 
   
  3.4 + 0.2 
    
   3.5 + 0.3 
Physical Symptoms  
Psychological Symptoms 
  
 
  2.0 + 0.3 
  3.4 + 0.1 
   1.6 + 0.2 
   3.0 + 0.2 
Sedation 
Appetite 
   3.8 + 0.2 
  2.0 + 0.3   
   3.0 + 0.2 
     3.7 + 0.4 
Total Score  14.4 + 0.7  14.9 + 0.8 
 
Fagerström Score  
   
   3.4 + 0.1
†
 
    
   3.5 + 0.2 
Urge to Smoke Score 
 
  
 
   12.3 + 1.1 
  
 39.4 + 4.2 
 
Expired Carbon Monoxide (ppm)     3.0 + 0.0       3.0 + 0.0       15.2 + 0.8* 
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Supplementary figure 1. Striatal and orbitofrontal regions taken from the Harvard-Oxford cortical and subcortical structural atlas, grouped 
together into one ROI mask. Higher-level (between-group) analyses were conducted using FLAME (FMRIB's Local Analysis of Mixed Effects).  
Significant clusters in this ROI mask of a priori regions were determined by thresholding at Z>2.3 with a corrected (FWE) cluster significance 
threshold of p<0.05.  
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